⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVTR News
Avantor, Inc.
Cell Therapy Technologies Market is expected to generate a revenue of USD 8.4 Billion by 2032, Globally, at 4.4% CAGR: Verified Market Research®
globenewswire.com
BDX
GEHC
LNN
MRK
TMO
AVTR
FMS
AVTR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit
prnewswire.com
AVTR
Avantor, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 29, 2025 to Discuss Your Rights - AVTR
prnewswire.com
AVTR
Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
accessnewswire.com
AVTR
New SueWallSt Podcast Covers Avantor, Inc. (AVTR) Class Action
accessnewswire.com
AVTR
Securities Lawsuit Alert: Avantor, Inc. (AVTR) Investors - Contact Levi & Korsinsky Before December 29, 2025
accessnewswire.com
AVTR
AVTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Avantor, Inc. to Contact the Firm Today!
accessnewswire.com
AVTR
Securities Lawsuit Alert: Avantor, Inc. (AVTR) Investors - Contact Levi & Korsinsky Before December 29, 2025
accessnewswire.com
AVTR
AVTR DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Avantor, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action - AVTR
globenewswire.com
AVTR
AVTR DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action - AVTR
accessnewswire.com
AVTR